ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
V

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluating the Effectiveness of Treatment in DLBCL

By ASCO 2022 Conference Coverage FEATURING Valeria Bandovkina
By ASCO 2022 Conference Coverage FEATURING Valeria Bandovkina
99 views
June 21, 2022
0 Comments
Login to view comments. Click here to Login
Lymphoma
04:26
ASCO 2022 Conference Coverage

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization o…

Feat. J. Dalpez
01:07
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequen…

Feat. J. Winter
09:39
ASCO 2022 Conference Coverage

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & …

Feat. J. Winter
01:13
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasi…

Feat. U. Vitolo
08:45
ASCO 2022 Conference Coverage

ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomi…

Feat. U. Vitolo
08:55
ASCO 2022 Conference Coverage

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using…

Feat. M. Trneny
10:16
ASCO 2022 Conference Coverage

ASCO 2022 ADCs and CARs: Racing to Cure Aggresive Lymphoma

Feat. K. Patel
13:02
ASCO 2022 Conference Coverage

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluati…

Feat. V. Bandovkina
11:30
ASCO 2022 Conference Coverage

ASCO 2022 Expert Discussion: Current Treatment Approaches in Hemophi…

Feat. J. Bussel, C. Mcguinn
01:44
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

Feat. M. Di
05:39
ASCO 2022 Conference Coverage

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

Feat. M. Di
05:16
ASCO 2022 Conference Coverage

ASCO 2022 Three-Year Follow-Up of Outcomes With KTE-X19 in R/R Mantl…

Feat. M. Wang
53
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Three-Year Follow-Up of Outcomes With KT…

Feat. M. Wang
05:40
ASCO 2022 Conference Coverage

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

Feat. P. Jain
57
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

Feat. P. Jain
07:46
ASCO 2022 Conference Coverage

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

Feat. M. Matasar
03:32
ASCO 2022 Conference Coverage

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of…

Feat. M. Loh
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Real World Experience of Combined Treatm…

Feat. M. Kalac
12:56
ASCO 2022 Conference Coverage

ASCO 2022 Real World Experience of Combined Treatment With Romidepsi…

Feat. M. Kalac
01:33
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as …

Feat. J. Abeykoon
10:06
ASCO 2022 Conference Coverage

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

Feat. J. Abeykoon
42
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, R…

Feat. J. Westin
05:27
ASCO 2022 Conference Coverage

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-La…

Feat. J. Westin
04:35
ASCO 2022 Conference Coverage

ASCO 2022 on CRC-403: A Phase 1/2 Study of bbT369, A Dual Targeting …

Feat. F. Locke
34
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

Feat. C. Lee Batlevi
05:16
ASCO 2022 Conference Coverage

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

Feat. C. Lee Batlevi
05:13
ASCO 2022 Conference Coverage

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Eff…

Feat. R. Steiner